Atezolizumab: A novel PD-L1 inhibitor in cancer therapy with a focus in bladder and non-small cell lung cancers (Q38685361)
Jump to navigation
Jump to search
scientific article published on April 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Atezolizumab: A novel PD-L1 inhibitor in cancer therapy with a focus in bladder and non-small cell lung cancers |
scientific article published on April 2017 |
Statements
1 reference
Atezolizumab: A novel PD-L1 inhibitor in cancer therapy with a focus in bladder and non-small cell lung cancers (English)
1 reference
A Krishnamurthy
1 reference
A Jimeno
1 reference
1 April 2017
1 reference
1 reference
53
1 reference
4
1 reference
217-237
1 reference
Identifiers
1 reference
1 reference